History
  • No items yet
midpage
130 F. Supp. 3d 764
W.D.N.Y.
2015
Read the full case

Background

  • Plaintiff RDC sues Biogen Idec U.S. Corp. over termination of their Avonex distribution contract.
  • Defendant terminated RDC’s distributorship effective July 1, 2015, directing Avonex sales to the Big Three wholesalers only.
  • Complaint asserts five claims: Donnelly Act violation, injunctive relief, anticipatory breach, breach of good faith and fair dealing, and declaratory relief.
  • Court granted motion to dismiss under Rule 12(b)(6); preliminary injunction petitions denied.
  • Court emphasizes industry context: Big Three dominate distribution and many pharmacies rely on them; termination could affect rural access to Avonex.
  • Court holds that the complaint fails to plead a plausible reciprocal arrangement with the Big Three to restrain trade; thus Donnelly Act claim dismissed with prejudice.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the Donnelly Act claim is plausible. D RDC argues a reciprocal arrangement existed with the Big Three. Biogen contends unilateral action suffices lacks reciprocal arrangement. Donnelly Act claim dismissed; no plausible reciprocal arrangement pled.
Whether unilateral distributor termination can violate Donnelly Act. Unilateral exertion can fall within Donnelly Act. Mobil Oil requires reciprocal relationship; unilateral acts fall outside statute. Unilateral action alone is insufficient to plead Donnelly Act liability.
Whether the complaint adequately alleges a reciprocal, bipartite arrangement with the Big Three. Alleges Big Three would benefit from the plan and could reassess volumes. No specific factual misconduct by Big Three; termination could be independent. No adequate factual basis for a reciprocal arrangement; claim dismissed.
Whether remaining claims survive after Donnelly Act dismissal. Claims premised on Donnelly Act or bad-faith arrangement should proceed. Without viable Donnelly Act claim or bad-faith conduct, other claims fail. Remaining claims dismissed for lack of viable antitrust/bad-faith theory.
What pleading standard applies to circumstantial antitrust claims under Twombly/Iqbal. Circumstantial evidence suffices for Donnelly Act claims. Plaintiff must plead plausible facts; here it does not. Pleading deemed insufficient; dismissal upheld.

Key Cases Cited

  • Monsanto Co. v. Spray-Rite Serv. Corp., 465 U.S. 752 (U.S. 1984) (unilateral refusals generally allowed under the Colgate doctrine)
  • Colgate & Co., 250 U.S. 300 (S. Ct. 1919) (Colgate doctrine: unilateral refusal to deal generally lawful)
  • Mobil Oil Corp., 38 N.Y.2d 460 (N.Y. 1976) (reciprocal relationship required for Donnelly Act liability)
  • In re Elevator Antitrust Litig., 502 F.3d 47 (2d Cir. 2007) (conspiracies must be inferred from behavior; labels insufficient)
  • Anderson News, L.L.C. v. Am. Media, Inc., 680 F.3d 162 (2d Cir. 2012) (conspiracies generally proven through inferences from conduct)
  • Yankees Entm’t & Sports Network, LLC v. Cablevision Sys. Corp., 224 F. Supp. 2d 657 (S.D.N.Y. 2002) (need to plead facts showing bilateral action or reciprocal relationship)
  • Twombly, 550 U.S. 544 (U.S. 2007) (plausibility standard; not mere labels or speculation)
  • Chambers v. Time Warner, Inc., 282 F.3d 147 (2d Cir. 2002) (consideration of integral documents in motion to dismiss when appropriate)
Read the full case

Case Details

Case Name: Rochester Drug Cooperative, Inc. v. Biogen IDEC U.S. Corp.
Court Name: District Court, W.D. New York
Date Published: Sep 18, 2015
Citations: 130 F. Supp. 3d 764; 2015 WL 5474666; No. 6:15-CV-6388 EAW
Docket Number: No. 6:15-CV-6388 EAW
Court Abbreviation: W.D.N.Y.
Log In
    Rochester Drug Cooperative, Inc. v. Biogen IDEC U.S. Corp., 130 F. Supp. 3d 764